Zhejiang Anglikang Pharmaceutical Co., Ltd.
3 clinical trials · Sponsor
◉ Watch Zhejiang Anglikang Pharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Phase Ib/II Study Evaluating Injectable ALK-N001 in Patients With Advanced Solid Tumors (NCT07509684) | Zhejiang Anglikang Pharmaceutical Co., Ltd. | 2026-04-01 |
| A First-in-Human Study of ALK-N001 for Injection in Patients With Advanced Solid Tumors (NCT07529535) | Zhejiang Anglikang Pharmaceutical Co., Ltd. | 2025-06-05 |
| Phase I Study of BM2216 ER vs. Melogabalin Besilate: Safety, PK, and Food Effect in Healthy Adults (NCT06846567) | Zhejiang Anglikang Pharmaceutical Co., Ltd. | 2024-12-01 |
Track Zhejiang Anglikang Pharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.